3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Prostatic Neoplasms
3
Prostate Cancer Metastatic
2
Myasthenia Gravis
2
Multiple Myeloma
2
Waldenstrom Macroglobulinemia
1
Subcutaneous panniculitis-like T-cell lymphoma
1
Skin Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Pneumonia
1
Pituitary Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoblastic Lymphadenopathy
1
Enteropathy-Associated T-Cell Lymphoma
1
Dementia
1
Craniopharyngioma
1
Cognitive Dysfunction
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Adrenal Insufficiency
1
Interventions
ravulizumab
1
Prednisone
1
Prednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Adrenal Insufficiency
×
Prednisone
×
Clear all
NCT07221838
2026-04-09
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4
Recruiting
75 enrolled